Hims & Hers completes acquisition of Eucalyptus parent Juniper platform
Hims & Hers Health
Hims & Hers Health HIMS | 0.00 |
- Hims & Hers completed its acquisition of Eucalyptus, parent of weight-management platform Juniper, expanding its footprint in Canada.
- The deal follows Hims & Hers’ 2025 Canadian launch, where it became the first platform to offer generic semaglutide to eligible patients.
- The combined business aims to scale Juniper’s weight-management program using Hims & Hers’ technology, data, and clinical infrastructure.
- Care for existing Juniper patients will continue without interruption, with ongoing connections to Canadian healthcare providers.
- The expanded platform targets additional Canadian growth areas such as sexual health and hair loss, alongside broader preventive care.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606020500BIZWIRE_USPR_____20260602_BW648634) on June 02, 2026, and is solely responsible for the information contained therein.
